Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile - Wikidata - awgldk - TriplyDB

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

http://www.wikidata.org/entity/Q33656103

about

CD40 in coronary artery disease: a matter of macrophages?The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis The Roles of CD137 Signaling in Atherosclerosis Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell Macrophages in the pathogenesis of atherosclerosis Phenotypic modulation of macrophages in response to plaque lipids.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.CD40L and Its Receptors in Atherothrombosis-An Update Inflammation and its resolution as determinants of acute coronary syndromes.The influence of ezetimibe on classical and alternative activation pathways of monocytes/macrophages isolated from patients with hypercholesterolemia.Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans.CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury Platelets and their chemokines in atherosclerosis-clinical applications.Macrophages in atherosclerosis: a dynamic balance.Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Involvement of DNA-PKcs in the IL-6 and IL-12 response to CpG-ODN is mediated by its interaction with TRAF6 in dendritic cells.Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells.TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity.Regulation of monocyte functional heterogeneity by miR-146a and Relb.Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway.Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice.Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway.Apolipoprotein E induces antiinflammatory phenotype in macrophages Macrophage polarization in metabolic disorders: functions and regulation A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation.Niche Regulation of Limbal Epithelial Stem Cells: Relationship between Inflammation and Regeneration Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation.HC-HA/PTX3 Purified From Amniotic Membrane as Novel Regenerative Matrix: Insight Into Relationship Between Inflammation and Regeneration Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response.CD40 promotes MHC class II expression on adipose tissue macrophages and regulates adipose tissue CD4+ T cells with obesity.Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study.Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.

P2860

Q26752784-870879D7-69B8-4BA0-8D24-30326D923195 Q26996707-38EB592A-5EFE-44B3-97ED-A591669529DD Q28076613-FFE20E45-F926-4234-94DD-5CA5838C08C8 Q28397011-D09E3889-4148-4045-9A61-C8CF5A271BD8 Q29617765-B8573CA8-31B0-42C3-9B63-5CF9B974EDD4 Q30413906-A83D0D30-BC14-479B-B48C-ADB1DF97371D Q30497499-E3564F76-3B09-42D1-A9D9-FC3808F7F03A Q30849102-15CA1BFE-5EA4-455E-879E-CFD216BCEC42 Q33814059-43927C25-9A36-40A4-8C09-F673DAA45048 Q33834800-A988387C-B6F6-4654-A866-89E67563F242 Q33883204-18F09178-9FD2-4F6C-B811-EEC937B29458 Q33996260-8AB809B4-D519-420D-8710-F14D0818347E Q34005419-CC29B19D-43A3-445D-A352-8F014D46FBE8 Q34019069-282F5BAC-07E2-4D3F-BA03-A0E68B2782A2 Q34368005-485C25F3-EB9A-4490-9892-0914F3DEF19F Q34428468-A9F62B51-E2E6-4423-825B-699C2D750795 Q34579752-2D005ECD-806A-414C-A5CF-E7A162488737 Q34637635-23521ABB-7AE0-470A-AFA3-3A2CAFC34426 Q34795130-7A07A019-E956-413F-88C7-F8D4F47B286D Q35104236-2F55311C-CCA9-44DC-98C6-6F99DDB0D1EC Q35621648-3FF5E3B6-4637-43A0-9456-449F27B902E8 Q35879683-306CF225-4660-450C-A725-5317B4460BFB Q35894071-2E2B0645-BDDD-46E1-A378-C6ACA979F049 Q35906690-5ED0F896-61D0-43F9-98CA-59B0510A2B53 Q35924786-59B0829D-6389-47D4-9641-BD26E9858AE6 Q35926299-A8A9DE22-098F-45F9-8217-B95D7C63F1C7 Q36000924-C3E5B55A-86E1-4BA9-9000-83CCB4CFB12E Q36486217-4CEDC43F-239C-46E5-BE79-F8260749FDBB Q36591717-B1095849-9E54-4B08-8532-C2F1CAEE7D34 Q36781352-7258C946-71F4-4EF1-955D-6C83B6068600 Q36829110-7D7C6CE7-F90D-4A3D-B3FB-17E4570A6FAA Q36841086-6A75F0B0-9B33-49D1-979B-76D20D237B82 Q36867016-8515DB1F-45D4-4CF3-8784-8F8EC23D4A2C Q36903682-0ED3957F-4D63-4532-A3AA-99EDF26C4FE8 Q37111264-6E613EC5-C2A1-45FF-A5C2-5D0AB8661039 Q37126212-EB67B3F4-AE6D-481A-AB8E-A3FD03C0045B Q37150998-3782B3E5-7E89-47F4-B40E-A8F0F2D7838B Q37407750-7604F20C-849A-4A93-B535-67C22D4796B8 Q37494039-E238339B-5AE9-4916-A5AA-6D12D8209481 Q37548680-20C5EA1B-2AE1-49C8-8B4B-3BA72282F626

P2860

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

http://www.wikidata.org/entity/Q33656103

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@ast

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@en

type

label

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@ast

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@en

prefLabel

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@ast

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@en

P1433

Q33656103-E91ABB37-09C3-425C-AF39-C0BD5A6D2C5B

P1476

Q33656103-C8F83760-592A-48A8-BDBD-4CF14122D5D3

P2093

Q33656103-2C9C9A9A-4B3B-491D-8E9A-1B10B9F4D7A7

Q33656103-4E9CE974-E2D3-45E3-9581-96E8287DFDD6

Q33656103-5DF198CB-0169-421C-B1D3-301CA0067D13

Q33656103-6D282DE9-E60F-473B-8E73-4A08D46ABF09

Q33656103-7A8A25AE-FEC2-460A-AE2D-B523241E16DF

Q33656103-838177F5-B417-42CC-9BA5-43069641ADBB

Q33656103-860FE57A-54E5-41E3-86AD-818535559D27

Q33656103-8B7D80B5-9627-48D3-987F-6C1AF70B411C

Q33656103-8CEBBFA2-8B99-4AB6-A7B3-3A20D14DCE30

Q33656103-91FB5D28-6134-4E62-B5E4-72BAE75FD81E

P2860

Q33656103-15E1AC99-ADF4-4EC8-9866-9DE9150D466B

Q33656103-1D82752A-9D1A-4B82-AB6F-9E37557DA140

Q33656103-213C2875-57BA-4304-8D0D-A830F2C0FA3D

Q33656103-2BEDBF8A-D26D-4E2A-B35F-55801B63FD19

Q33656103-2F24879F-E44A-421F-88F0-671CD5B328F9

Q33656103-321FB573-A77A-4F72-959E-FD5B794260B0

Q33656103-353C2EDC-77AC-4802-B8F2-9CAB4F1351B4

Q33656103-436167AA-CFE9-4EA1-994C-6A733113326D

Q33656103-46DA3FD1-CE8E-49A1-82F3-4D37852928FA

Q33656103-4F36A27A-80AA-427F-83EE-1F204D0E9611

P304

Q33656103-E997EE07-78CE-4B5F-A627-9E7A7218C8A4

P31

Q33656103-782092A6-3AC6-42D2-BBD4-16E3F071A04F

P356

Q33656103-E0C01AC0-BFF6-402E-ABC8-86029D4845A2

P407

Q33656103-047FC6BD-B6DA-4575-9D1D-F5A2434FAFFA

P433

Q33656103-7894979D-A688-4699-9203-BBE4D5CD820E

P478

Q33656103-5E09933F-ECC4-471A-8257-2D4053BFEDBB

P50

Q33656103-11493F4A-1BFB-441C-8481-D587CD4000A0

Q33656103-55C94282-14A5-4586-BA34-666516947E1D

Q33656103-7DBB9D47-E3ED-4B8A-9668-14AC275B228F

Q33656103-97765F0A-1074-4AFC-B2A2-C689773BA236

P577

Q33656103-9DA3EEA8-1226-457E-9AEC-41D737E0516A

P5875

Q33656103-49DF5C6E-17CB-47BA-84F8-21553380BCBE

P698

Q33656103-EA8C3239-B943-44EB-80F0-EDEA2CFBACF8

P921

Q33656103-BB5906C6-5BB7-447A-9C53-7822CC09930E

P932

Q33656103-90870D5D-F9B5-442A-B9CF-4F27E80DCDA8

P356

P1433

Journal of Experimental Medicine

P1476

Deficient CD40-TRAF6 signaling ...... rd an antiinflammatory profile

@en

P2093

Anna M Keller

http://www.w3.org/2001/XMLSchema#string

Cory L Ahonen

http://www.w3.org/2001/XMLSchema#string

David Engel

http://www.w3.org/2001/XMLSchema#string

Dirk Lievens

http://www.w3.org/2001/XMLSchema#string

Erik A Biessen

http://www.w3.org/2001/XMLSchema#string

Erwin Wijnands

http://www.w3.org/2001/XMLSchema#string

Esther Lutgens

http://www.w3.org/2001/XMLSchema#string

Hafid Ait Oufella

http://www.w3.org/2001/XMLSchema#string

Jack Cleutjens

http://www.w3.org/2001/XMLSchema#string

Linda Beckers

http://www.w3.org/2001/XMLSchema#string

P2860

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Exploring the full spectrum of macrophage activation

Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40

Alternative activation of macrophages

TRAF6 is a critical factor for dendritic cell maturation and development

Inflammation, atherosclerosis, and coronary artery disease

Alternative activation of macrophages: an immunologic functional perspective

The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

P304

391-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20091293

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

207

http://www.w3.org/2001/XMLSchema#string

P50

Christian Weber

Menno de Winther

P577

2010-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41139185

http://www.w3.org/2001/XMLSchema#string

P698

20100871

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2822598

http://www.w3.org/2001/XMLSchema#string